A carregar...
Implementing a clozapine supply service in Australian community pharmacies: barriers and facilitators
BACKGROUND: Clozapine is the most effective antipsychotic for treatment-resistant schizophrenia, although serious adverse effects such as agranulocytosis and cardiomyopathy limit its use. In July 2015, Australian regulations changed to allow community-based prescribing and supply of clozapine for ma...
Na minha lista:
| Publicado no: | J Pharm Policy Pract |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6685252/ https://ncbi.nlm.nih.gov/pubmed/31406580 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40545-019-0180-3 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|